[准新生儿Fc受体阻塞:重塑IgG介导自身免疫疾病的治疗格局]
1Department of Neurology, the First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052, China.
Zhonghua yi xue za zhi
|August 5, 2025
概括
新生儿Fc受体 (FcRn) 抑制剂通过降低致病性IgG水平,为自身免疫性疾病提供了有前途的新疗法. 临床研究表明这些抑制剂是有效和安全的,尽管需要进一步的研究来实现个性化治疗.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 类风湿病学 类风湿病学
背景情况:
- 自身免疫性疾病涉及免疫系统对自身组织的攻击,导致炎症和损伤.
- 致病性免疫球蛋白G (IgG) 是自身免疫性疾病进展的核心.
- 现有治疗方法在有效性和副作用方面存在局限性.
研究的目的:
- 评估新生儿Fc受体 (FcRn) 抑制剂在治疗自身免疫性疾病中的疗效和安全性.
- 突出FcRn抑制剂在减少致病性IgG的作用机制.
- 确定FcRn抑制剂治疗的未来研究方向.
主要方法:
- 对FcRn抑制剂的多项高质量的临床研究的综述.
- 分析FcRn抑制剂阻断FcRn-IgG相互作用的机制.
- 对各种IgG介导的自身免疫疾病的疗效和安全性数据的评估.
主要成果:
- FcRn抑制剂有效降低致病性IgG水平,导致器官损伤减少.
- 临床试验表明FcRn抑制剂具有显著的疗效和良好的安全性.
- 患者反应的变化和最佳剂量需要进一步调查.
结论:
- FcRn抑制剂代表了自身免疫性疾病治疗的重大进展.
- 需要进一步研究结构优化,扩大适应症,组合疗法和个性化剂量.
- FcRn抑制剂对改善自身免疫性疾病患者的治疗结果有很大的前景.
相关概念视频
Transcytosis of IgG
2.9K
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
2.9K
Development of Immunocompetence
448
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
448
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
233
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
233


